Rituximab Is Associated With Late Onset Neutropenia (Lon) When Administered With Doxorubicin-Based Chemotherapy For The Initial Treatment Of Aggressive B-Cell Lymphomas. KM Dunleavy,RF Little,N Grant,T White,G Wright,J Janik,WH WilsonBLOOD(2003)引用 4|浏览1暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要